Your browser doesn't support javascript.
loading
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1.
Neirich, Leonie; Yahiaoui-Doktor, Maryam; Lammert, Jacqueline; Basrai, Maryam; Seethaler, Benjamin; Berling-Ernst, Anika; Ramser, Juliane; Quante, Anne S; Schmidt, Thorsten; Niederberger, Uwe; Rhiem, Kerstin; Schmutzler, Rita; Engel, Christoph; Bischoff, Stephan C; Halle, Martin; Kiechle, Marion; Grill, Sabine.
Afiliação
  • Neirich L; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, University Hospital Rechts der Isar, Technical University of Munich (TUM), Munich, Germany. leonie.neirich@mri.tum.de.
  • Yahiaoui-Doktor M; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
  • Lammert J; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, University Hospital Rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Basrai M; Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.
  • Seethaler B; Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.
  • Berling-Ernst A; Department of Prevention, Rehabilitation and Sports Medicine, Faculty of Medicine, University Hospital Rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Ramser J; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, University Hospital Rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Quante AS; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, University Hospital Rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Schmidt T; Institute of Human Genetics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Niederberger U; Comprehensive Cancer Center, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Rhiem K; Institute for Medical Psychology and Medical Sociology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Schmutzler R; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.
  • Engel C; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.
  • Bischoff SC; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
  • Halle M; Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.
  • Kiechle M; Department of Prevention, Rehabilitation and Sports Medicine, Faculty of Medicine, University Hospital Rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Grill S; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Breast Cancer Res Treat ; 190(3): 463-475, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34570303
PURPOSE: Emerging evidence suggests that the progesterone-mediated receptor activator of nuclear factor κB (RANK)/soluble RANK ligand (sRANKL)/osteoprotegerin (OPG) pathway plays an important role in mammary carcinogenesis and is hyperactivated in germline (g)BRCA1/2 mutation carriers. We analyzed the effects of a 3-month intensive lifestyle intervention within the LIBRE-1 study on the serum levels of OPG and sRANKL and hypothesized that the intervention program provides a beneficial impact on the biomarkers by increasing OPG and reducing sRANKL serum concentrations. METHODS: Serum levels of OPG and sRANKL of 49 gBRCA1/2 mutation carriers were quantified using enzyme-linked immunosorbent assays. We used previously collected blood samples from participants of the prospective LIBRE-1 study, who were randomized into an intervention group (IG), increasing physical activity and adherence to the Mediterranean diet (MedD) through supervised sessions from study entry to the first study visit after 3 months and a usual-care control group (CG). Differences in biomarker levels before and after the 3-month intervention were tested within and between study groups. RESULTS: The lifestyle intervention resulted in a significant increase in OPG for participants in both the IG (q = 0.022) and CG (q = 0.002). sRANKL decreased significantly in the IG (q = 0.0464) and seemed to decrease in the CG (q = 0.5584). An increase in the intake of Omega-3 polyunsaturated fatty acids was significantly associated with an increase in OPG (r = 0.579, q = 0.045). Baseline serum levels of sRANKL were a strong predictor for the change of sRANKL in the course of the intervention (ß-estimate = - 0.70; q = 0.0018). Baseline physical fitness (assessed as VO2peak) might predict the change of OPG in the course of the intervention program (ß-estimate = 0.133 pg/ml/ml/min/kg; p = 0.0319; q = 0.2871). CONCLUSION: Findings from this pilot study seem to confirm our hypothesis by showing an increase in OPG and decrease in sRANKL over a 3-month lifestyle intervention and suggest that increased physical activity and adherence to the MedD are potent modulators of the biomarkers OPG and potentially sRANKL.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Estudos Prospectivos / Proteína BRCA1 / Dieta Mediterrânea / Osteoprotegerina Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Estudos Prospectivos / Proteína BRCA1 / Dieta Mediterrânea / Osteoprotegerina Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha